Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia

Journal of Pharmaceutical Health Care and Sciences
Masayuki HashiguchiMayumi Mochizuki

Abstract

The benefit of Ginkgo biloba for the treatment of dementia remains controversial. The aim of this study was to evaluate the efficacy and safety of Ginkgo biloba in patients with dementia in whom administration effects were reported using meta-analysis. We searched MEDLINE, Embase, the Cochrane databases, and Ichushi for controlled trials of Ginkgo biloba for the treatment dementia. Clinical characteristics and outcomes were extracted. Meta-analysis results were expressed as standard mean differences (SMDs) in scores of the Syndrome Kurztest (SKT), Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) for cognition efficacy, or odds ratios (ORs) for dropouts and adverse drug reactions. Thirteen studies using the extract EGb761 met our inclusion criteria, which were duration of 12 to 52 weeks and daily dose of more than 120 mg, and included a total of 2381 patients. Meta-analysis was performed by using 9 of 13 studies, 7 of which used the SKT and 2 ADAS-Cog (dose 120 mg, 26 weeks) scores as efficacy parameters. In meta-analysis of all patients, SMDs (95% confidence interval [CI]) in the change in SKT scores (7 studies) were in favor of Ginkgo biloba over placebo (SMD = -0.90 [-1.46, -0.34]), but 2 studies that used A...Continue Reading

References

Nov 1, 1984·The American Journal of Psychiatry·W G RosenK L Davis
Jan 1, 1993·Journal of Clinical Psychology·Y S KimJ E Overall
Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Oct 29, 1997·JAMA : the Journal of the American Medical Association·P L Le BarsA F Schatzberg
Feb 3, 1998·Journal of Psychiatric Research·K MaurerL Frölich
Jun 29, 1999·Clinical Otolaryngology and Allied Sciences·E Ernst, C Stevinson
Jun 27, 2000·Dementia and Geriatric Cognitive Disorders·P L Le BarsK Z Itil
Jan 1, 1996·American Journal of Therapeutics·Turan M. ItilUlrich Stein
May 28, 2003·Journal of Clinical Epidemiology·Martien van DongenPaul Knipschild
Aug 26, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M MazzaS Mazza
Mar 17, 2009·Journal of the Neurological Sciences·Oleksandr NapryeyenkoIgor Tartakovsky
Mar 20, 2010·BMC Geriatrics·Stefan WeinmannStefan N Willich
May 6, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Susanna UsaiGennaro Bussone
May 24, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Jerome SarrisAndrew Scholey
Jun 20, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Natascia BrondinoPierluigi Politi

❮ Previous
Next ❯

Citations

Jan 21, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Parvana Hajieva
Jan 14, 2017·Medicinal Research Reviews·Sergey O BachurinAleksey A Ustyugov
May 1, 2020·The American Journal of Chinese Medicine·Phui Zee ChongShaun Wen Huey Lee
Dec 7, 2017·Zeitschrift für Gerontologie und Geriatrie·Bernhard Iglseder
Jun 2, 2020·British Journal of Clinical Pharmacology·Christina San San Tan, Shaun Wen Huey Lee
Aug 17, 2019·Current Vascular Pharmacology·Hoa Thi PhuGianfranco Pintus
Dec 14, 2018·Drugs & Therapy Perspectives : for Rational Drug Selection and Use·Kate McKeage, Katherine A Lyseng-Williamson
Jan 19, 2019·International Journal of Molecular Sciences·Francesco PotìIlaria Zanotti
Apr 3, 2020·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Mayumi Mochizuki
Mar 24, 2018·Journal of Natural Medicines·Tingfu LiangMasaru Tanokura
Jan 31, 2020·Frontiers in Pharmacology·Sílvia M IllamolaElena Y Enioutina
Apr 23, 2020·Frontiers in Pharmacology·Abdullah ShaitoGianfranco Pintus
May 1, 2021·Pharmaceuticals·Carlo TominoPaolo Maria Rossini
May 1, 2021·Biomolecules·Julie GregoryRammohan V Rao

❮ Previous
Next ❯

Software Mentioned

Review Manager

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Cochrane Database of Systematic Reviews
Jacqueline S Birks, John Grimley Evans
The Cochrane Database of Systematic Reviews
Jacqueline S BirksJohn Grimley Evans
International Psychogeriatrics
H J Möbius, A Stöffler
© 2021 Meta ULC. All rights reserved